ADCT
ADC Therapeutics SA
1.10$
+4.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | -17.6% | +0.0% | +354.4% | +67.7% | -100.0% | – | – | – | – | +0.0% | +0.0% | -92.8% | +249.7% | +29.4% | +173.4% | -62.8% | +341.4% | -8.5% | -72.8% | +1.5% | -24.8% | +15.8% | +7.5% | -3.6% | +6.1% | -8.4% | +36.2% | -18.2% | -12.8% | +40.4% | -13.1% | -3.9% | – | |
| – | +0.0% | -2.9% | +0.0% | -20.0% | -6.6% | +40.4% | -0.4% | +16.3% | -26.6% | +23.9% | -19.3% | -97.8% | -79.1% | +314.9% | +53.4% | -31.3% | +328.4% | -42.9% | -62.2% | -105.5% | – | -67.7% | +34,092.6% | -98.0% | -51.5% | -30.1% | +61.1% | +50.3% | -59.4% | +43.8% | +41.3% | +112.8% | -35.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -102.2% | – | +247.5% | +28.4% | +183.1% | -67.3% | +399.3% | -7.6% | -72.6% | -4.6% | -22.2% | -867.0% | – | +4.2% | +8.8% | -11.8% | +35.0% | -14.2% | -15.4% | +40.3% | -23.1% | +2.9% | – | |
| – | +0.0% | -3.2% | +0.0% | -20.0% | -6.6% | +40.4% | -0.4% | +16.3% | -26.6% | +23.9% | +51.0% | -19.3% | +0.9% | -6.9% | +15.5% | +15.2% | -0.8% | -14.1% | +16.9% | -21.3% | -18.3% | -9.3% | +6.6% | -15.2% | -5.6% | +33.8% | -16.6% | +6.7% | +4.0% | -10.9% | -32.2% | +9.3% | -12.6% | – | |
| – | +0.0% | +26.6% | +0.0% | +34.6% | +24.1% | -43.7% | +113.7% | +19.6% | +154.9% | +35.2% | -0.9% | -12.5% | +10.2% | -14.4% | +70.3% | -32.7% | +9.2% | +36.0% | -46.4% | +55.7% | -23.1% | -17.0% | -25.0% | +55.9% | -8.6% | -2.9% | -3.0% | -34.3% | +50.3% | -6.3% | +11.2% | -36.5% | -2.0% | – | |
| – | +0.0% | +17.4% | +0.0% | +40.4% | +676.2% | +27.1% | +8.8% | +22.8% | +2.4% | +16.6% | +48.8% | -9.4% | +4.9% | -5.0% | +12.2% | +9.3% | -2.2% | -7.5% | +2.4% | -13.5% | -16.5% | -10.8% | -232.7% | – | -8.0% | +17.6% | -9.8% | +3.0% | +25.7% | -26.7% | -13.3% | +5.5% | +1.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | – | – | – | -1.4% | -11.1% | +59.4% | -17.6% | +2,035.7% | +116.3% | +5.5% | -2.3% | +27.8% | +66.9% | +123.2% | -3.2% | -4.5% | +29.0% | -13.7% | +5.0% | +0.2% | +25.5% | -40.7% | +62.8% | +1.5% | +3.5% | -9.1% | +2.6% | +6.3% | +3.0% | -2.8% | -5.1% | +9.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -48.6% | +0.0% | +161.8% | -5.5% | +185.1% | -57.1% | -13.0% | +4.0% | -102.9% | – | -15.1% | +124.3% | -39.6% | -15,252.4% | – | – | – | – | -86.9% | -968.3% | – | – | -99.6% | +43.6% | -61.5% | -456.7% | – | +660.0% | -121.2% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -423.0% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.